Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KYNU | Q16719 | 1/20 | 0.49 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.45 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.45 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.45 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 6/20 | 0.44 |
| ▸ | CTSL | P07711 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29402191 | 0.94 | CASP1 (0.47) | CASP1BCHEACHECACNA1FCACNA1D | |
| SCHEMBL10313730 | 0.94 | CASP1 (0.47) | CASP1BCHEACHECACNA1FCACNA1D | |
| SCHEMBL31614372 | 0.94 | CASP1 (0.47) | CASP1BCHEACHECACNA1FCACNA1D | |
| SCHEMBL7299901 | 0.92 | BCHE (0.50) | SIRT2SIRT1SIRT3ALDH1A1CASP1 | |
| SCHEMBL13418028 | 0.88 | CASP1 (0.43) | CASP1BCHEACHECACNA1FCACNA1D | |
| SCHEMBL6706623 | 0.88 | BCHE (0.54) | SIRT2SIRT1SIRT3ALDH1A1CASP1 | |
| SCHEMBL7130286 | 0.86 | BCHE (0.48) | SIRT2SIRT1SIRT3ALDH1A1BCHE | |
| SCHEMBL29401031 | 0.86 | KLK7 (0.47) | BCHEACHECTSKCTSLCTSS | |
| SCHEMBL2777934 | 0.86 | SYK (0.46) | CASP1BCHEACHECACNA1FCACNA1D | |
| SCHEMBL7998762 | 0.86 | CASP1 (0.50) | CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124317-A2 | Antibody Drug Conjugates | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| US-20250135026-A1 | Antibody Drug Conjugates | BEIGENE SWITZERLAND GMBH (CH) | 2025-05-01 | — | — | US | disclosed |
| CN-118450907-A | Antibody drug conjugates | 百济神州有限公司 | 2024-08-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124317-A2 | Antibody Drug Conjugates | SLC3A2, SLC7A1, SLC43A1 | KYNU 1108/4885SIRT2 1049/4885SIRT1 1307/4885 |
| US-20250135026-A1 | Antibody Drug Conjugates | CD22, FCGR2A, FCGR3B | KYNU 4202/4885SIRT2 2339/4885SIRT1 3465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.